Skip to content

LSD and ketanserin and their impact on the human autonomic nervous system

Sebastian Olbrich, Katrin H. Preller, Franz X. Vollenweider

Psychophysiology March 27, 2021 DOI: 10.1111/psyp.13822 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Randomized, placebo-controlled crossover trial Peer reviewed
Interventions LSD ketanserin
Topics LSD
Keywords Ketanserin Placebo Autonomic nervous system Analysis of variance Hallucinogen Heart rate variability Parasympathetic nervous system Crossover study Psychopathology Vagal tone
Citations 34
Key findings LSD predominantly increased sympathetic activity, while ketanserin counteracted this effect via an increase of parasympathetic tone, and sympathetic activity was positively while parasympathetic activity was negatively associated with psychedelic effects.

Abstract

Abstract The interest in lysergic acid diethylamide (LSD) has sparked again due to its supposed positive effects on psychopathological conditions. Yet, most research focuses on the actions of LSD on the central nervous system. The interaction with the autonomic nervous system (ANS) has been neglected so far. Therefore, the aim was to assess the effects of LSD and the serotonin 2A receptor antagonist ketanserin on the ANS as assessed by heart rate variability (HRV) measures and their correlation with subjective drug‐induced effects in a randomized, placebo‐controlled crossover trial. Thus, ANS activity was derived from electrocardiogram recordings after intake of placebo, LSD or ketanserin, and LSD by calculating R‐peak‐based measures of sympathetic and parasympathetic activity. Repeated measure ANOVA and partial correlation for HRV measures and subjective experience questionnaires were performed. LSD predominantly increased sympathetic activity, while ketanserin counteracted this effect on the ANS via an increase of parasympathetic tone. Sympathetic activity was positively and parasympathetic activity negatively associated with psychedelic effects of LSD. Furthermore, Placebo HRV measures predicted subjective experiences after LSD intake. The association between trait ANS activity and LSD‐induced subjective experiences may serve as a candidate biomarker set for the effectiveness of LSD in the treatment of psychopathological conditions.

Comparable studies

Other randomized controlled trials on LSD, most cited first.

Study Year Design Participants
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Patients with anxiety associated with life-threatening diseases 2014 Randomized controlled trial n = 12
Dose-Response Study of N,N-Dimethyltryptamine in Humans Experienced hallucinogen users 1994 Double-blind, saline placebo-controlled, randomized study n = 12
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects Healthy subjects (8 women, 8 men) 2014 Double-blind, randomized, placebo-controlled, crossover study n = 16
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor Healthy human participants 2018 Double-blind, randomized, counterbalanced, cross-over study n = 24
LSD-induced entropic brain activity predicts subsequent personality change. Healthy adults 2016 Balanced-order, placebo-controlled study n = 19

Citations in the library

Cited by 26

and 21 more in the library

Cites 19

and 14 more in the library

Related reading

Explore topics

LSD Mystical experience Serotonin